Developing Therapeutics for Rare Pediatric Diseases with Nevan Elam Rezolute

Published: Feb. 3, 2020, 6:10 p.m.

Nevan Elam, J.D. CEO and co-founder Rezolute, Inc. talks about their work developing therapeutics for congenital hyperinsulinism, a rare pediatric disease and for diabetic macular edema, a vision-related complication of diabetes.  With a background of working with technology businesses, Nevan reflects on lessons learned and differences in drivers of innovation in the computer and biotech worlds.

@rezolutebio

#RareDisease #PediatricDisease #DME #DiabeticMacularEdema #Diabetes #hyperinsulinism

RezoluteBio.com

Download the transcript here